- Home
- KYMR vs QUBT Comparison
KYMR vs QUBT Comparison
Compare KYMR & QUBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- QUBT
- Stock Information
- Founded
- KYMR 2015
- QUBT 2001
- Country
- KYMR United States
- QUBT United States
- Employees
- KYMR N/A
- QUBT N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- QUBT Computer Manufacturing
- Sector
- KYMR Health Care
- QUBT Technology
- Exchange
- KYMR Nasdaq
- QUBT Nasdaq
- Market Cap
- KYMR 3.1B
- QUBT 2.7B
- IPO Year
- KYMR 2020
- QUBT N/A
- Fundamental
- Price
- KYMR $47.28
- QUBT $16.84
- Analyst Decision
- KYMR Strong Buy
- QUBT Buy
- Analyst Count
- KYMR 15
- QUBT 2
- Target Price
- KYMR $58.53
- QUBT $18.50
- AVG Volume (30 Days)
- KYMR 599.5K
- QUBT 15.9M
- Earning Date
- KYMR 10-30-2025
- QUBT 11-05-2025
- Dividend Yield
- KYMR N/A
- QUBT N/A
- EPS Growth
- KYMR N/A
- QUBT N/A
- EPS
- KYMR N/A
- QUBT N/A
- Revenue
- KYMR $44,711,000.00
- QUBT $263,000.00
- Revenue This Year
- KYMR $58.45
- QUBT $64.08
- Revenue Next Year
- KYMR N/A
- QUBT $383.33
- P/E Ratio
- KYMR N/A
- QUBT N/A
- Revenue Growth
- KYMR N/A
- QUBT N/A
- 52 Week Low
- KYMR $19.45
- QUBT $0.64
- 52 Week High
- KYMR $53.27
- QUBT $27.15
- Technical
- Relative Strength Index (RSI)
- KYMR 64.57
- QUBT 57.00
- Support Level
- KYMR $42.71
- QUBT $15.12
- Resistance Level
- KYMR $44.43
- QUBT $16.28
- Average True Range (ATR)
- KYMR 1.98
- QUBT 0.93
- MACD
- KYMR 0.60
- QUBT 0.24
- Stochastic Oscillator
- KYMR 91.51
- QUBT 80.32
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About QUBT Quantum Computing Inc.
Quantum Computing Inc is an integrated photonics and quantum optics technology company that provides accessible and affordable quantum machines to the world today. Its products are designed to operate at room temperature and low power at an affordable cost. The Company's portfolio of core technologies and products offer capabilities in the areas of high-performance computing, artificial intelligence, and cybersecurity, as well as remote sensing applications.